 | Up a level |
Motamed, N. and Nikkhah, M. and Karbalaie Niya, M.H. and khoonsari, M. and Perumal, D. and Ashrafi, G.H. and Faraji, A.H. and Maadi, M. and Ajdarkosh, H. and Safarnezhad Tameshkel, F. and Moradi-Lakeh, M. and Miri, S.M. and Arsang-Jang, S. and Zamani, F. (2021) The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study. Clinics and Research in Hepatology and Gastroenterology, 45 (6).
Motamed, N. and Ajdarkosh, H. and Ahmadi, M. and Perumal, D. and Ashrafi, G.H. and Nikkhah, M. and Faraji, A.H. and Maadi, M. and Khoonsari, M. and Rezaie, N. and Farahani, B. and Tameshkel, F.S. and Ameli, M. and Panahi, M. and Niya, M.H.K. and Zamani, F. (2020) Non-alcoholic fatty liver disease is not independent risk factor for cardiovascular disease event: A cohort study. World Journal of Hepatology, 12 (6). pp. 323-331.
Tabibzadeh, A. and Tameshkel, F.S. and Moradi, Y. and Soltani, S. and Moradi-Lakeh, M. and Ashrafi, G.H. and Motamed, N. and Zamani, F. and Motevalian, S.A. and Panahi, M. and Esghaei, M. and Ajdarkosh, H. and Mousavi-Jarrahi, A. and Niya, M.H.K. (2020) Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis. Scientific Reports, 10 (1).
